• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSL1600045 GLS-010注射液 Zimberelimab Injection Biological Products(1) New Drug Application 2016-06-06 哈尔滨誉衡药业股份有限公司 Harbin Gloria Pharmaceuticals Co Ltd Certificate Issued 2017-03-15 view
CXSL2300709 赛帕利单抗注射液 Zimberelimab Injection Biological Products(2.2) New Drug Application 2023-10-18 Gilead (Shanghai) Pharmaceutical Technology Co Ltd view
CYSB2200203 赛帕利单抗注射液 Zimberelimab Injection Biological Products Supplementary Application 2022-08-15 view
CXSL2300530 赛帕利单抗注射液 Zimberelimab Injection Biological Products(2.2) New Drug Application 2023-08-01 Guangzhou Gloria Biosciences Co Ltd view
CXSS2200025 赛帕利单抗注射液 Zimberelimab Injection Biological Products(2.2) New Drug Application 2022-03-15 view
CXSL2400475 赛帕利单抗注射液 Zimberelimab Injection Biological Products(2.2) New Drug Application 2024-07-24 Gilead (Shanghai) Pharmaceutical Technology Co Ltd view
CXSL2300188 赛帕利单抗注射液 Zimberelimab Injection Biological Products(2.2) New Drug Application 2023-03-15 Gilead (Shanghai) Pharmaceutical Technology Co Ltd view
CXSL2200132 赛帕利单抗注射液 Zimberelimab Injection Biological Products(2.2) New Drug Application 2022-03-18 Guangzhou Gloria Biosciences Co Ltd view
CYSB2400017 赛帕利单抗注射液 Zimberelimab Injection Biological Products Supplementary Application 2024-01-17 view
CXSS2000005 赛帕利单抗注射液 Zimberelimab Injection Biological Products(1) New Drug Application 2020-02-21 无锡药明生物技术股份有限公司,广州誉衡生物科技有限公司 Certificate Issued 2021-09-02 view
CXSL2300708 赛帕利单抗注射液 Zimberelimab Injection Biological Products(2.2) New Drug Application 2023-10-18 Gilead (Shanghai) Pharmaceutical Technology Co Ltd view
CYSB2200274 赛帕利单抗注射液 Zimberelimab Injection Biological Products Supplementary Application 2022-12-08 view